• Contact us
  • Advertise with us
  • Login
Tashi Pharma
  • Home
  • Indian Pharma News
  • Global Pharma News
  • Guideline News
    • All
    • EDQM
    • EMA
    • European Commision
    • Health Canada
    • Medsafe
    • MHRA
    • SAHPRA
    • US FDA
    FDA Clinical Trial Guidances for Advancing Development of Cancer Treatments

    FDA publishes Clinical Trial Guidances for Advancing Development of Cancer Treatments

    Initiation of Voluntary Recalls Under 21 CFR Part 7, Subpart C

    US FDA publishes guidance on Initiation of Voluntary Recalls

    EMA publishes Q & A for Bootstrap methodology for f2 similarity factor

    EMA publishes Q & A on Bootstrap methodology for f2 similarity factor

    US FDA publishes product-specific guidances to facilitate generic drug development

    US FDA publishes product-specific guidances to facilitate generic drug development

    Clinical Trials Regulation comes into effect in the EU

    New Clinical Trials Regulation comes into effect in the EU

    Reflection paper Forecasting demand for medicinal products in the EU_EEA

    EMA publishes reflection paper on forecasting demand for medicinal products in the EU/EEA

    Trending Tags

    • Pharma
    • EMA
    • MHRA
    • TGA
    • US FDA
  • Articles
  • Interview
  • Company Focus
  • Pharma Jobs
    • Quality
    • Regulatory Affairs
    • Production
    • Sales and Marketing
    • Clinical
    • bioanalytical
  • Webinar
No Result
View All Result
  • Home
  • Indian Pharma News
  • Global Pharma News
  • Guideline News
    • All
    • EDQM
    • EMA
    • European Commision
    • Health Canada
    • Medsafe
    • MHRA
    • SAHPRA
    • US FDA
    FDA Clinical Trial Guidances for Advancing Development of Cancer Treatments

    FDA publishes Clinical Trial Guidances for Advancing Development of Cancer Treatments

    Initiation of Voluntary Recalls Under 21 CFR Part 7, Subpart C

    US FDA publishes guidance on Initiation of Voluntary Recalls

    EMA publishes Q & A for Bootstrap methodology for f2 similarity factor

    EMA publishes Q & A on Bootstrap methodology for f2 similarity factor

    US FDA publishes product-specific guidances to facilitate generic drug development

    US FDA publishes product-specific guidances to facilitate generic drug development

    Clinical Trials Regulation comes into effect in the EU

    New Clinical Trials Regulation comes into effect in the EU

    Reflection paper Forecasting demand for medicinal products in the EU_EEA

    EMA publishes reflection paper on forecasting demand for medicinal products in the EU/EEA

    Trending Tags

    • Pharma
    • EMA
    • MHRA
    • TGA
    • US FDA
  • Articles
  • Interview
  • Company Focus
  • Pharma Jobs
    • Quality
    • Regulatory Affairs
    • Production
    • Sales and Marketing
    • Clinical
    • bioanalytical
  • Webinar
No Result
View All Result
No Result
View All Result
Home Company Focus

J. B. Chemicals and Pharmaceuticals Ltd – legacy continues……

By Khushi Masarani

PRN by PRN
May 20, 2021
in Company Focus
56 1
0
J.B.Chemicals & Pharmaceuticals Ltd

Logo of J.B.Chemicals & Pharmaceuticals Ltd

37
SHARES
87
VIEWS

The Beginning

J.B. Chemicals & Pharmaceuticals Ltd. (JBCPL) significantly referred to as Unique Pharmaceutical Laboratories, mounted in 1976 is one of India’s fastest-growing pharmaceutical companies. The organisation is primarily based totally via Mr J.B. Mody along collectively at the side of his brothers, Mr D.B. Mody and Mr S.B. Mody has its headquarters at Mumbai. The organisation is significantly famous and relied on for itś products in every Indian and International market. JBCPL significantly manufactures drugs, intermediates, formulations, ayurvedic tablets, injectable (vials, ampoules, form fill seal), creams & ointments, lozenges, herbal drinks and capsules.

Prestigious Organization

J.B. Chemicals & Pharmaceuticals Ltd. (JBCPL) has its predominant interest in making the lives of humans better with the useful resource of the usage of imparting their low price and high-best first-rate products. Their predominant interest is to end up global well-known manufacturers of first-rate pharmaceutical products with the useful resource of the usage of excelling withinside the fields of research, regulatory and manufacturing. JBCPL has manufacturing operations being environmentally first-rate in Maharashtra and Gujarat. JBCPLs facilities are built and operated consistent with GMP requirements and had been legal with the useful resource of the usage of reputed global inspection businesses collectively with the UK MHRA, MCC South Africa, TGA Australia, ANVISA Brazil, INVIMA Colombia, Ukraine-MOH, FDB Ghana and NAFDAC Nigeria and plenty of more.

JBCPL organisation has acquired many prestigious awards, certificates, honours and recognitions since 1996. Some of the decent and noteworthy awards are the National Export Award for the year 1996-97, from the Hon’ble Ex-Prime Minister of India, Shri. Atal Bihari Vajpayee, the ‘Niryat Shree’ Certificate of Excellence award, with the aid of the Federation of Indian Export Organisations (FIEO) for the year 2004-2005. It has additionally been featured withinside the Forbes Global listing a hundred for “Best under $1 Billion” in Asia-Pacific in 2004 and additionally in 2005. It had gotten a worldwide repute and acknowledgement in international locations together with Russia, Ukraine, South Africa and in international locations like CIS to J&J.

A New Path

JBCPL has been taken over through KKR ultimate year, paying Rs 3,100 crore for a 54% stake. He is making plans to feature on the whole attention in cardio-metabolic, oral breathing and paediatrics segments. The organisation that’s mainly in regions along with Hypertension have now released a brand new section in India withinside the Nephrology, including a brand new region acknowledged as ¨RENOVA¨  for the sufferers who’re going under a remedy of Chronic Kidney Disease ( CKD ) which has been understood more trouble because the instances were growing and to fulfil the wishes of the sufferers remedies is turning into a trouble for the Nephrologists and the Physicians as withinside the later degrees of CKD the sufferers’ mortality charge is increased.

Philanthropic Organization

JBCPL contributors additionally invest their precious money and time in social welfare, efforts in making an environmentally pleasant vicinity for everybody with the aid of growing and making mother nature better. It additionally brings remarkable outputs in the Healthcare quarter with the aid of doing a long way extra assist than we can count on from them.

In the education sector, JBCPL has founded the B.K. Mody Pharmacy College in Rajkot, Gujarat in the memory of late B.K. Mody is run by the Government of Gujarat today. JBCPL has also founded the J.B. Mody School in Bharuch an educational centre that brings the best academic performance and moral values out of the students. JBCPL has founded three Anganwadi (People school) for the youngest children in rural areas like Ankleshwar and Bharuch. JBCPL has also provided computer and internet facilities to widen the career choices for students in B.J medical college in Ahmedabad. JBCPL has also donated a table tennis room to Rotary Sports Centre, Bharuch.

In the health care sector, Smt. Jayaben Mody Hospital in Ankleshwar was built through the Mody Brothers in memory of their late mom Smt. Jayaben Mody has all of the contemporary-day services and facilities to assist not only the commercial community but also the poorer peoples of South Gujarat. Shri. Sardar Vallabhbhai Patel Rotary General Hospital had been bridged for the households who stay beneath the poverty line in rural regions of Gujarat through the Mody family. A fund has been additionally raised referred to as Poor Patient Fund, to assist poor sanatorium sufferers in Bharuch and Ankleshwar. A Rotary Diagnostic Center is evolved as a charitable facility with radiology and pathology diagnostics for the terrible and needy. Several different hospitals have been set up with maternity wards, burns wards etc. in rural and concrete regions consisting of Sewa rural, Jhagadia, GT Sheth Hospital, Rajkot, CU Shah Hospital, Surendranagar and Hindu Sabha Hospital in Ghatkopar, Mumbai.

The enterprise has additionally reconstructed the village of Vavania and rebuilt 126 residing units for the sufferer households after the Gujarat earthquake. To make the environmental, pollutants free JBCPL additionally supported a gas-primarily based totally crematorium in Bharuch. A lawn named J.B. Mody Garden is constructed and operated through the Mody family is one of the nice gardens in Bharuch and has leisure centres for children, together with a joggers park. An IMA, Lions Bardoli Community Hall and Fountain withinside the centre of Bharuch town are likewise constructed and run by Mody Family. Shrimad Rajchandra Temple at Rajkot, Vavania, Agas, Koba, London, Prempuri Ashram, Shrimad Rajchandra Temple at Vavania is set up and run by Mody Family.

(Author of the article Khushi Masarani. Khushi is independent writer & blogger in space of Healthcare & life sciences. The views expressed in the article are solely those of the author in her private capacity)

Tags: J.B.Chemicals & Pharmaceuticals Ltd.
Previous Post

Colorcon opens New Containment Suite for Handling High Potency APIs at its Global Technical Center in Harleysville, USA

Next Post

Unichem receives ANDA approval for its Amitriptyline HCl Tablets

PRN

PRN

Related Posts

Cyclica- An artificial intelligence-based drug discovery company
Company Focus

Cyclica – An artificial intelligence based drug discovery company

by PRN
May 28, 2021
Torrent Pharmaceuticals, a journey towards excellence……
Company Focus

Torrent Pharmaceuticals, a journey towards excellence……

by PRN
May 9, 2021
Next Post
Unichem receives ANDA approval for its Amitriptyline HCl Tablets

Unichem receives ANDA approval for its Amitriptyline HCl Tablets

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Recent News

Zydus to launch Oxemia

Zydus to launch Oxemia (Desidustat) a treatment for Anemia in patients with Chronic Kidney Disease (CKD)

March 7, 2022
FDA Urges Companies to be 'Recall Ready’ to Protect Public Health as Part of Final Guidance for Voluntary Recalls

US FDA Urges Companies to be ’Recall Ready’ to Protect Public Health

March 6, 2022
FDA Clinical Trial Guidances for Advancing Development of Cancer Treatments

FDA publishes Clinical Trial Guidances for Advancing Development of Cancer Treatments

March 5, 2022
Initiation of Voluntary Recalls Under 21 CFR Part 7, Subpart C

US FDA publishes guidance on Initiation of Voluntary Recalls

March 5, 2022
Kilitch Drugs Commences Rs. 100 Crore New Facility Expansion Plan

Kilitch Drugs Commences Rs. 100 Crore New Facility Expansion Plan

March 5, 2022

Browse by Category

  • Articles
  • Company Focus
  • EDQM
  • EMA
  • European Commision
  • Global Pharma News
  • Guideline News
  • Health Canada
  • Indian Pharma News
  • Interview
  • Medsafe
  • MHRA
  • SAHPRA
  • US FDA
  • Webinar

Browse by Tags

Abbott Alembic alkem Amgen Amneal AstraZeneca bayer biocon Biogen BioNTech Bristol Myers Squibb cipla covid Daiichi Sankyo drreddy Eli Lilly fda Gilead glenmark gsk Incyte Janssen Jubilant lupin MHRA Moderna Natco Novartis Novavax novo nordisk oncology Panacea Biotech Pfizer pharmacy Pharma News Pharmareg News Remdesivir roche sanofi Sun pharma Teva usfda Vaccine Viatris zydus

Contact us

Address:Pharma Reg News, First floor, Shop no.1 , Plot no 241,242, Near Fire station, GIDC, Ankleshwar, Gujarat - 393002.
Phone:+91 8511586232, +91 9029066605
Email:author@pharmaregnews.com

Browse by Tag

Abbott Alembic alkem Amgen Amneal AstraZeneca bayer biocon Biogen BioNTech Bristol Myers Squibb cipla covid Daiichi Sankyo drreddy Eli Lilly fda Gilead glenmark gsk Incyte Janssen Jubilant lupin MHRA Moderna Natco Novartis Novavax novo nordisk oncology Panacea Biotech Pfizer pharmacy Pharma News Pharmareg News Remdesivir roche sanofi Sun pharma Teva usfda Vaccine Viatris zydus

Advertise with us

© 2021 - Pharmaregnews.com. Developed by YESWEUS.

No Result
View All Result
  • Home
  • Indian Pharma News
  • Global Pharma News
  • Guideline News
    • EMA
    • MHRA
    • TGA
    • US FDA
  • Articles
  • Interview
  • Company Focus
  • Pharma Jobs
    • Quality
    • Regulatory Affairs
    • Production
    • Sales and Marketing
    • bioanalytical
    • Clinical
  • Webinar
  • Contact us
  • Advertise with us
  • Login

© 2021 - Pharmaregnews.com. Developed by YESWEUS.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?